I think Cynata correctly forecast the latest knock back by the FDA.
Really? Where did any Cynata official. Kilian or anyone else forecast the latest knock back - I must have missed that.
That's my interpretation of Cynata (under Ross's reign) doing a CR for the P2 FDA trial for GVHD in May. If you look at what is being said by MSB now regarding the FDA, GVHD is GVHD (kids/adults/other), which is in line with what I always thought. I reckon there was no chance the CYP P2 would of progressed if approval was given. I think RM 'retired' when he did in case MSB did get approval.
All IMO. And I am never to be relied upon - obviously.
CYP Price at posting:
15.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)